Advertisement
BDMD vs INFU
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDMD is a StrongBuy and INFU is a Buy.
BDMD in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 19, 2026
BDMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 31 cases where BDMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDMD advanced for three days, in 68 of 116 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BDMD as a result. In 34 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
The Moving Average Convergence Divergence Histogram (MACD) for BDMD turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 13 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 29%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for BDMD entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.410) is normal, around the industry mean (2.906). P/E Ratio (-0.807) is within average values for comparable stocks, (2.003). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.371) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. BDMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
INFU in downward trend: price expected to drop as it breaks its higher Bollinger Band on October 20, 2026
INFU broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 29 similar instances where the stock broke above the upper band. In 26 of the 29 cases the stock fell afterwards. This puts the odds of success at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for INFU moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 18 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for INFU just turned positive on October 20, 2026. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in 41 of 61 cases over the following month. The odds of a continued upward trend are 67%.
Following a +6.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in 173 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 87 of 137 cases where INFU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.694) is normal, around the industry mean (2.906). P/E Ratio (33.190) is within average values for comparable stocks, (2.003). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.817) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
INFU | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 94 | |
SMR RATING 1..100 | 56 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 67 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BDMD | INFU | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 75% | 3 days ago 78% |
| Stochastic ODDS (%) | 3 days ago 45% | 3 days ago 89% |
| Momentum ODDS (%) | 3 days ago 47% | N/A |
| MACD ODDS (%) | 3 days ago 29% | 3 days ago 67% |
| TrendWeek ODDS (%) | 3 days ago 62% | 3 days ago 69% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 75% |
| Advances ODDS (%) | 19 days ago 59% | 6 days ago 66% |
| Declines ODDS (%) | 3 days ago 83% | 25 days ago 79% |
| BollingerBands ODDS (%) | 3 days ago 84% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDMD’s FA Score shows that 0 FA rating(s) are green while INFU’s FA Score has 0 green FA rating(s).
- BDMD’s FA Score: 0 green, 5 red.
- INFU’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDMD’s TA Score shows that 4 TA indicator(s) are bullish while INFU’s TA Score has 3 bullish TA indicator(s).
- BDMD’s TA Score: 4 bullish, 4 bearish.
- INFU’s TA Score: 3 bullish, 4 bearish.
Price Growth
BDMD (@Medical/Nursing Services) experienced а -21.29% price change this week, while INFU (@Medical/Nursing Services) price change was +4.03% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was -10.64%.
Reported Earning Dates
INFU is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.51% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FYLD | 40.00 | 0.03 | +0.08% |
| Cambria Foreign Shareholder Yield ETF (FYLD) | |||
| CPLS | 33.82 | -0.06 | -0.18% |
| AB Core Plus Bond ETF (CPLS) | |||
| OCTU | 30.71 | -0.12 | -0.37% |
| AllianzIM U.S. Equity Buffer15 Uncapped Oct ETF (OCTU) | |||
| SPYQ | 189.71 | -1.93 | -1.01% |
| Tradr 2X Long SPY Quarterly ETF (SPYQ) | |||
| PSLV | 17.37 | -0.27 | -1.53% |
| Sprott Physical Silver Trust | |||
BDMD and
Correlation & Price change
A.I.dvisor tells us that BDMD and INFU have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDMD and INFU's prices will move in lockstep.
| Ticker / NAME | Correlation To BDMD | 1D Price Change % | ||
|---|---|---|---|---|
| BDMD | 100% | -4.89% | ||
| INFU - BDMD | 22% Poorly correlated | -1.41% | ||
| DCTH - BDMD | 22% Poorly correlated | -2.24% | ||
| CERS - BDMD | 21% Poorly correlated | +0.87% | ||
| LFWD - BDMD | 20% Poorly correlated | +2.54% | ||
| BWAY - BDMD | 20% Poorly correlated | -1.66% | ||
More | ||||